AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Paliperidone

11 registrations across 2 African markets— 9 active

Markets with Paliperidone

Recent registrations

Brand / ProductMarketHolderStatusExpires
PALIDO 6
Film-Coated Tablet
🇰🇪KenyaOMILIFE LIMITEDactiveJul 2029
PALIDO 3
Film-Coated Tablet
🇰🇪KenyaOMILIFE LIMITEDactiveJul 2029
INVEGA 12 mg🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdsuspendedDec 2022
INVEGA 9 mg🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdsuspendedNov 2022
INVEGA 3 mg🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900
XEPLION 50 mg/0,50 ml🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900
XEPLION 25 mg/0,25 ml🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900
XEPLION 75 mg/0,75 ml🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900
XEPLION 100 mg/1,0 ml🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900
XEPLION 150 mg/1,50 ml🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900
INVEGA 6 mg🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900

Paliperidone in Africa — Regulatory Overview

Paliperidone is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Kenya. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 9 (82%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.